[EN] PROCESS OF SYNTHESIZING AND PURIFYING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTANOATE<br/>[FR] PROCÉDÉ DE SYNTHÈSE ET DE PURIFICATION DE (R)-3-HYDROXYBUTANOATE DE (R)-3-HYDROXYBUTYLE
申请人:GENOMATICA INC
公开号:WO2021231271A1
公开(公告)日:2021-11-18
A process for synthesizing (R)-3 -hy droxybutyl (R)-3 -hy droxybutanoate from ethyl (R)-3-hydroxybutanoate and (R)-l,3-butanediol, as well a process for synthesizing (R)-3-hy droxybutyl (R)-3-hy droxybutanoate from (R)-3-hydroxybutyric acid and (R)-l,3-butanediol. Also provided are processes for isolating (R)-3-hy droxybutyl (R)-3-hy droxybutanoate, including from a fermentation broth.
The present invention is directed to a novel taste-masking composition comprising a taste-masking effective amount of an
Angelica
root extract, which shows unexpected effectiveness in reducing an undesirable taste in a food product (e.g., a beverage, broth, or whole grain food product), a dental product, an oral hygiene product or a medicinal product.
[EN] HAIR CONDITIONING COMPOSITION COMPRISING CARBOXYLIC ACID/CARBOXYLATE COPOLYMER, SILICONE COMPOUND, AND HIGH MELTING POINT COMPOUND<br/>[FR] COMPOSITION POUR LE CONDITIONNEMENT DES CHEVEUX COMPRENANT UN COPOLYMERE ACIDE CARBOXYLIQUE/CARBOXYLATE, UN COMPOSE DE SILICONE ET UN COMPOSE AYANT UN POINT DE FUSION ELEVE
申请人:PROCTER & GAMBLE
公开号:WO2000006098A1
公开(公告)日:2000-02-10
Disclosed is a hair conditioning composition comprising: (1) a carboxylic acid/carboxylate copolymer; (2) a silicone compound; (3) a high melting point compound; and (4) an aqueous carrier.
COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID FOR TREATING MYOCARDIAL INFARCTION IN A SUBJECT ON CONCOMITANT STATIN THERAPY
申请人:Amarin Pharmaceuticals Ireland Limited
公开号:EP3698781A1
公开(公告)日:2020-08-26
In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof.
在各种实施方案中,本发明提供了治疗和/或预防心血管相关疾病的组合物和方法。
PHARMACEUTICAL COMPOSITIONS COMPRISING EPA
申请人:Amarin Pharmaceuticals Ireland Limited
公开号:EP3791880A1
公开(公告)日:2021-03-17
The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same.